Preemptive antiviral therapy in lung transplantation from hepatitis C donors results in a rapid and sustained virologic response
JTCVS Open(2023)
摘要
Recipients of hepatitis C virus nucleic acid test positive lungs have similar survival as recipients of nucleic acid test negative lungs. Preemptive direct-acting antiviral therapy results in rapid viral clearance and sustained virologic response at 12 months. Preemptive direct-acting antiviral may partially prevent hepatitis C virus transmission.
更多查看译文
关键词
lung transplantation,hepatitis C,outcomes,antivirals
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要